Oral administration of tilapia hydrolysate peptides ameliorates the immune-related side effects of cyclophosphamide in BALB/c mice

Oral administration of tilapia hydrolysate peptides ameliorates the immune-related side effects of cyclophosphamide in BALB/c mice

Bioactive peptide derived from fish is a novel and promising immunomodulating agent. However, the use of tilapia peptides as adjuvant therapy to ameliorate chemotherapy-induced immunosuppression in vivo has not been previously studied. In this study, tilapia hydrolysate peptides (THP) with a low mol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food bioscience 2023-12, Vol.56, p.103428, Article 103428
Hauptverfasser: Liu, Kuan-Yu, Kuo, I-Pei, Chen, Yu-Ju, Lee, Po-Tsang, Lee, Chia-Jung
Format: Artikel
Sprache:eng
Schlagworte:
Anticancer adjunctive therapy
bioactive peptide
Cyclophosphamide
immunomodulatory activity
tilapia byproducts
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Bioactive peptide derived from fish is a novel and promising immunomodulating agent. However, the use of tilapia peptides as adjuvant therapy to ameliorate chemotherapy-induced immunosuppression in vivo has not been previously studied. In this study, tilapia hydrolysate peptides (THP) with a low molecular weight distribution (
ISSN:2212-4292
2212-4306
DOI:10.1016/j.fbio.2023.103428